Your account is not claimed yet. You can sign up with ORCID to claim your account.

Yinghan Chan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

Nanomedicine (London, England)

Nanomaterials (Basel, Switzerland)

Journal of food biochemistry

Future medicinal chemistry

University of Malaya

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Malaya

Malaysia

Research Assistant :: Department of Pharmacology, Faculty of Medicine

Publications

Juman Mohammed Rasmi Alamil, Keshav Raj Paudel, Yinghan Chan, Dikaia Xenaki, Jithendra Panneerselvam, Dinesh Kumar Chellapan, Monica Gulati, Niraj Kumar Jha, Deepak Kumar, Parteek Prasher, Gaurav Gupta, Raniya Malik, Brian Gregory George Oliver, Philip Michael Hansbro, Kamal Dua, Dinesh Kumar Chellappan
Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases. Molecules (Basel, Switzerland) 27 (9) (2022)
Keshav Raj Paudel, Vyoma Patel, Sukriti Vishwas, Saurabh Gupta, Sumit Sharma, Yinghan Chan, Niraj Kumar Jha, Jesus Shrestha, Mohammad Imran, Nisha Panth, Shakti Dhar Shukla, Saurav Kumar Jha, Hari Prasad Devkota, Majid Ebrahimi Warkiani, Dinesh Kumar Chellapan, Md Khadem Ali, Gaurav Gupta, Dinesh Kumar Chellappan, Philip Michael Hansbro, Kamal Dua
Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications. Journal of food biochemistry (2022)
Yinghan Chan, Ronan MacLoughlin, Flavia C Zacconi, Murtaza M Tambuwala, Ritesh M Pabari, Dinesh Kumar Chellapan, Terezinha de Jesus Andreoli Pinto, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua
Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine (London, England) 16 (16) (2021)
Yinghan Chan, Parteek Prasher, Raimar Löbenberg, Dinesh Kumar Chellappan, Dinesh Kumar Chellapan, Brian Gregory George Oliver, Dinesh Kumar Chellappan, Kamal Dua
Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases. Nanomedicine (London, England) 16 (10) (2021)
Yinghan Chan, Xun Hui Wu, Buong Woei Chieng, Nor Azowa Ibrahim, Yoon Yee Then
Superhydrophobic Nanocoatings as Intervention against Biofilm-Associated Bacterial Infections. Nanomaterials (Basel, Switzerland) 11 (4) (2021)
Yinghan Chan, Meenu Mehta, Keshav Raj Paudel, Thiagarajan Madheswaran, Jithendra Panneerselvam, Dinesh Kumar Chellappan, Qian Peter Su, Philip Michael Hansbro, Ronan MacLoughlin, Kamal Dua, Dinesh Kumar Chellappan
Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (London, England) 16 (18) (2021)
Yinghan Chan, Sin Wi Ng, Meenu Mehta, Dinesh Kumar Chellappan, Kamal Dua
Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld. Future medicinal chemistry 12 (21) (2020)

Yinghan Chan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yinghan Chan